|

Itraconazole Clinical Trials

12 actively recruiting trials across 8 locations

Also known as: Onmel, Sporanox, Tolsura

Pipeline

Phase 1: 6Phase 2: 2Phase 1/2: 4

Top Sponsors

  • Pfizer2
  • DualityBio Inc.2
  • VA Office of Research and Development1
  • Kura Oncology, Inc.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Cancer12
  • Lung Cancer5
  • Breast Cancer4
  • Liver Disease2
  • Advanced Solid Tumors2

Other3 trials

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1
Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors
Phase 1
Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer
Phase 1

Tucson, Arizona2 trials

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 111

Phase 1/2
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Banner-University Medical Center Tucson

Phase 1

Gilbert, Arizona1 trial

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Banner MD Anderson Cancer Center

Phase 1/2

Scottsdale, Arizona1 trial

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

HonorHealth

Phase 1

Cerritos, California1 trial

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Helios Clinical Research

Phase 1/2

Palo Alto, California1 trial

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

VA Palo Alto Health Care System, Palo Alto, CA

Phase 2

San Francisco, California1 trial

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco

Phase 1/2

New Haven, Connecticut1 trial

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Pfizer Clinical Research Unit - New Haven

Phase 1

Dallas, Texas1 trial

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Dallas VA Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.